B. Metzler Sells 10% of Amgen Holdings Amid Hedge Fund Shift

B. Metzler seel. Sohn & Co. AG has reduced its holdings in Amgen Inc. (NASDAQ:AMGN) by 10.4% in the second quarter, according to its latest Form 13F filing with the Securities and Exchange Commission.

The fund owned 39,041 shares of the medical research company's stock after selling 4,539 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Amgen were worth $14,137,000 as of its most recent filing with the Securities and Exchange Commission.

This is not an isolated case, as other hedge funds have also modified their positions in AMGN during the second quarter. For instance, Impax Asset Management Group plc increased its stake by 4.6% and now owns 18,289 shares of Amgen's stock worth $6,623,000.